Bristol-Myers Squibb CEO: "I Feel Really Good About Where We Are Going"
Fresh off an earnings beat, Bristol-Myers Squibb CEO Giovanni Caforio told CNBC Thursday he is confident in the company's pipeline and its portfolio.
The drugmaker, who saw its high-profile Opdivo immunotherapy fail an important lung-cancer trial last summer, sharply raised its 2016 profit forecast after strong quarterly sales of other leading medicines.
"I feel really good about where we are as a company. I feel really good about where we are going," Caforio said in an interview with "Power Lunch."
The drugmaker, who saw its high-profile Opdivo immunotherapy fail an important lung-cancer trial last summer, sharply raised its 2016 profit forecast after strong quarterly sales of other leading medicines.
"I feel really good about where we are as a company. I feel really good about where we are going," Caforio said in an interview with "Power Lunch."